Cro Splendid Lab Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -30.17%
- Profit Growth -25.82%
- Ebitda -31.89%
- Net Worth 21.20%
- Total Assets -11.97%
About Cro Splendid Lab
Cro Splendid Lab Private Limited (CSLPL) is a Private Limited Indian Non-Government Company incorporated in India on 22 March 2016 (Eight years and ten months 11 days old ). Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Abhay Gandhi and Pritam Gandhi serve as directors at the Company.
Company Details
-
Location
Pune, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U74999PN2016PTC158959
-
Company No.
158959
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
22 Mar 2016
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
What products or services does Cro Splendid Lab Private Limited offer?
Cro Splendid Lab Private Limited offers a wide range of products and services, including Essential & Aromatic Oils, Menthol.
Who are the key members and board of directors at Cro Splendid Lab?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhay Gandhi
|
Director | 22-Mar-2016 | Current |
|
Pritam Gandhi
|
Director | 22-Mar-2016 | Current |
Financial Performance of Cro Splendid Lab.
Cro Splendid Lab Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 30.17% decrease. The company also saw a substantial fall in profitability, with a 25.82% decrease in profit. The company's net worth Soared by an impressive increase of 21.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cro Splendid Lab?
Unlock access to Cro Splendid Lab's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cro Splendid Lab?
Unlock and access historical data on people associated with Cro Splendid Lab, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cro Splendid Lab, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cro Splendid Lab's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.